| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Toxicology, National Institute of Occupational Health, P. O. Box 8149 Dep, 0033 Oslo 1 [G. T., A. H.]; Department of Occupational Medicine, Telemark Hospital, 3600 Porsgrunn [I-L. H.]; and Laboratory of Clinical Electron Microscopy, University of Bergen, 5021 Bergen [H. D.], Norway
The occupational and environmental hazards of nickel exposure are of great concern in environmental medicine. Nickel workers have increased risk of cancer of the nose, lung, larynx, and possibly the kidney. In the present investigation we have studied the effects of nickel ions on fetal human kidney cortex explants. The explants were continuously exposed to 5 µg/ml NiSO4. After 70100 days in culture foci of phenotypically altered cells appeared. Immortalized cell lines were established and demonstrated to be of human epithelial origin. Tumorigenicity was not induced, but the cells demonstrated decreased requirement for serum, increased plating efficiency and saturation density, and formation of colonies in soft agar. Chromosome changes in the treated cells were observed. Worth mentioning are change in ploidy (3n) and abnormalities of chromosomes 1, 7, 9, 11, 13, 14 and 20; increased numbers of chromosome 17; and loss of normal chromosomes 20 and 22.
1 This work was supported by the Norwegian Cancer Society.
2 To whom requests for reprints should be addressed.
Received 7/15/88. Revised 11/28/88. Accepted 1/ 4/89.
This article has been cited by other articles:
![]() |
K. Duning, E.-M. Schurek, M. Schluter, M. Bayer, H.-C. Reinhardt, A. Schwab, L. Schaefer, T. Benzing, B. Schermer, M. A. Saleem, et al. KIBRA Modulates Directional Migration of Podocytes J. Am. Soc. Nephrol., October 1, 2008; 19(10): 1891 - 1903. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, G. Davidson, Y. Huang, B.-H. Jiang, X. Shi, M. Costa, and C. Huang Nickel Compounds Act through Phosphatidylinositol-3-kinase/Akt-Dependent, p70S6k-Independent Pathway to Induce Hypoxia Inducible Factor Transactivation and Cap43 Expression in Mouse Epidermal Cl41 Cells Cancer Res., January 1, 2004; 64(1): 94 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Hirsch, N. Skutta, and E. Schlatter Signaling and distribution of NPR-Bi, the human splice form of the natriuretic peptide receptor type B Am J Physiol Renal Physiol, August 1, 2003; 285(2): F370 - F374. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. CCetinkaya, E. Schlatter, J. R. Hirsch, P. Herter, E. Harms, and R. Kleta Inhibition of Na+-Dependent Transporters in Cystine-Loaded Human Renal Cells: Electrophysiological Studies on the Fanconi Syndrome of Cystinosis J. Am. Soc. Nephrol., August 1, 2002; 13(8): 2085 - 2093. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sindice, C. Basoglu, A. Cerci, J. R. Hirsch, R. Potthast, M. Kuhn, Y. Ghanekar, S. S. Visweswariah, and E. Schlatter Guanylin, Uroguanylin, and Heat-stable Euterotoxin Activate Guanylate Cyclase C and/or a Pertussis Toxin-sensitive G Protein in Human Proximal Tubule Cells J. Biol. Chem., May 10, 2002; 277(20): 17758 - 17764. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. HIRSCH, M. MEYER, H.-J. MÄGERT, W.-G. FORSSMANN, S. MOLLERUP, P. HERTER, G. WEBER, R. CERMAK, I. ANKORINA-STARK, E. SCHLATTER, et al. cGMP-Dependent and -Independent Inhibition of a K+ Conductance by Natriuretic Peptides: Molecular and Functional Studies in Human ProximalTubule Cells J. Am. Soc. Nephrol., March 1, 1999; 10(3): 472 - 480. [Abstract] [Full Text] |
||||
![]() |
H.-M. Koo, M. Gray-Goodrich, G. Kohlhagen, M. J. McWilliams, M. Jeffers, A. Vaigro-Wolff, W. G. Alvord, A. Monks, K. D. Paull, Y. Pommier, et al. The ras Oncogene-Mediated Sensitization of Human Cells to Topoisomerase II Inhibitor-Induced Apoptosis J Natl Cancer Inst, February 3, 1999; 91(3): 236 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hohage, A. Stachon, C. Feidt, J. R. Hirsch, and E. Schlatter Regulation of Organic Cation Transport in IHKE-1 and LLC-PK1 Cells. Fluorometric Studies with 4-(4-Dimethylaminostyryl)N-methylpyridinium J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 305 - 310. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |